Leavell Investment Management, Inc. Crispr Therapeutics Ag Transaction History
Leavell Investment Management, Inc.
- $1.79 Billion
- Q2 2024
A detailed history of Leavell Investment Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 12,650 shares of CRSP stock, worth $594,423. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,650
Previous 10,500
20.48%
Holding current value
$594,423
Previous $715,000
4.48%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$370 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$366 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$148 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$148 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$131 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.67B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....